The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study
- 20 May 2009
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 7 (6) , 919-927
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- TAFI activity in coronary artery disease: A contribution to the current discussion on TAFI assaysThrombosis and Haemostasis, 2006
- High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic strokeJournal of Thrombosis and Haemostasis, 2005
- A new functional assay of thrombin activatable fibrinolysis inhibitorJournal of Thrombosis and Haemostasis, 2005
- Quantification of thrombin activatable fibrinolysis inhibitor (TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform-dependent artefactThrombosis and Haemostasis, 2005
- Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assaysBritish Journal of Haematology, 2004
- Risk of Ischemic Stroke Associated With Functional Thrombin-Activatable Fibrinolysis Inhibitor Plasma LevelsStroke, 2003
- Thrombin-Activable Fibrinolysis Inhibitor Levels in the Acute Phase of Ischemic StrokeStroke, 2003
- Score Tests for Association between Traits and Haplotypes when Linkage Phase Is AmbiguousThe American Journal of Human Genetics, 2002
- Myocardial infarction in young adults: Angiographic characterization, risk factors and prognosis (coronary artery surgery study registry)JACC, 1995
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985